30 November 2018 - Australian cancer sufferers will have greater and more affordable access to five treatments from Saturday.
Patients battling forms of leukaemia, advanced intestinal and pancreatic tumours, melanomas, bowel cancer and ovarian cancer will benefit from new listings on the Pharmaceutical Benefits Scheme.
Australians fighting those cancers will pay $39.50 per script, instead of up to $30,000 a year.